Here are five takeaways:
1. ReWalk Robotics offers external robotic skeletons for those suffering from spinal cord injuries. The company has a robotic device for both home and clinical rehabilitation use.
2. The offering is for about $6.9 million ordinary shares at $1.05 per share.
3. The gross proceedings equal about $7.2 million.
4. National Securities Corporation is the sole underwriter.
5. The offering will likely close Nov. 21.
More articles on devices:
Zimmer Biomet, K2M, Medicrea & more: 6 device company notes
Invibio invests resources to lower healthcare costs: 5 things to know
Medtronic CEO Omar Ishrak: 5 key points on the future of value-based care for device companies
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
